WINDLAS BIOTECH Financial Statement Analysis
|
||
The Revenues of WINDLAS BIOTECH have increased by 8.96% YoY .
The Earnings Per Share (EPS) of WINDLAS BIOTECH has increased by 16.53 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
WINDLAS BIOTECH Last 5 Annual Financial Results
[BOM: 543329|NSE : WINDLAS]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹466 Cr | ₹428 Cr | ₹329 Cr | ₹307 Cr | ₹352 Cr |
Expenses | ₹414 Cr | ₹373 Cr | ₹287 Cr | ₹269 Cr | ₹313 Cr |
Operating Profit (Excl OI) | ₹52 Cr | ₹55 Cr | ₹41 Cr | ₹39 Cr | ₹39 Cr |
Other Income | ₹6.71 Cr | ₹3.09 Cr | ₹2.49 Cr | ₹4.26 Cr | ₹4.21 Cr |
Interest | ₹1.42 Cr | ₹1.29 Cr | ₹2.53 Cr | ₹4.84 Cr | ₹6.47 Cr |
Depreciation | ₹12 Cr | ₹13 Cr | ₹9.29 Cr | ₹11 Cr | ₹17 Cr |
Profit Before Tax | ₹46 Cr | ₹22 Cr | ₹32 Cr | ₹77 Cr | ₹20 Cr |
Profit After Tax | ₹38 Cr | ₹16 Cr | ₹24 Cr | ₹65 Cr | ₹11 Cr |
Consolidated Net Profit | ₹38 Cr | ₹16 Cr | ₹16 Cr | ₹64 Cr | ₹11 Cr |
Earnings Per Share (Rs) | ₹20.37 | ₹17.48 | ₹24.70 | ₹25.29 | ₹99.55 |
PAT Margin (%) | 8.31 | 8.17 | 3.68 | 7.20 | 21.02 |
ROE(%) | 10.76 | 12.87 | 7.70 | 11.74 | 40.92 |
ROCE(%) | 14.39 | 14.88 | 9.93 | 15.05 | 40.49 |
Total Debt/Equity(x) | 0.00 | 0.02 | 0.16 | 0.13 | 0.15 |
Key Financials |
||
Market Cap | : | ₹ 1,136.1 Cr |
Revenue (TTM) | : | ₹ 600.4 Cr |
Net Profit(TTM) | : | ₹ 52.6 Cr |
EPS (TTM) | : | ₹ 25.3 |
P/E (TTM) | : | 21.6 |
Industry Peers & Returns | 1W | 1M | 1Y |
WINDLAS BIOTECH | -3.9% | 2.9% | 118.3% |
SUN PHARMACEUTICAL INDUSTRIES | -2.3% | -6.5% | 55.3% |
CIPLA | 4.1% | -4.8% | 55.6% |
DR REDDYS LABORATORIES | 4% | 0.8% | 29.4% |
ZYDUS LIFESCIENCES | -1.2% | -5.2% | 83.9% |
DIVIS LABORATORIES | 7.8% | 17.4% | 20.3% |
MANKIND PHARMA | 1.3% | 7% | NA |
TORRENT PHARMACEUTICALS | 3.9% | 5.1% | 66.1% |
LUPIN | 0.6% | 0.5% | 127.2% |
WINDLAS BIOTECH Revenues
[BOM: 543329|NSE : WINDLAS]
Y-o-Y | 8.96 % |
5 Yr CAGR | 7.25 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹466 Cr | 8.96 | |
Mar2022 | ₹428 Cr | 30.03 | |
Mar2021 | ₹329 Cr | 7.02 | |
Mar2020 | ₹307 Cr | -12.76 | |
Mar2019 | ₹352 Cr | - |
WINDLAS BIOTECH Operating Profit
[BOM: 543329|NSE : WINDLAS]
Y-o-Y | -4.15 % |
5 Yr CAGR | 7.45 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹52 Cr | -4.15 | |
Mar2022 | ₹55 Cr | 31.90 | |
Mar2021 | ₹41 Cr | 7.68 | |
Mar2020 | ₹39 Cr | -2.10 | |
Mar2019 | ₹39 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -12.04 % |
5 Yr CAGR | 0.18 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 11.25% | -12.04 | |
Mar2022 | 12.79% | 1.43 | |
Mar2021 | 12.61% | 0.64 | |
Mar2020 | 12.53% | 12.18 | |
Mar2019 | 11.17% | - |
WINDLAS BIOTECH Profit After Tax
[BOM: 543329|NSE : WINDLAS]
Y-o-Y | 140.58 % |
5 Yr CAGR | 35.80 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹38 Cr | 140.58 | |
Mar2022 | ₹16 Cr | -2.35 | |
Mar2021 | ₹16 Cr | -74.60 | |
Mar2020 | ₹64 Cr | 469.94 | |
Mar2019 | ₹11 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 1.71 % |
5 Yr CAGR | -20.71 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 8.31 % | 1.71 | |
Mar2022 | 8.17 % | 122.01 | |
Mar2021 | 3.68 % | -48.89 | |
Mar2020 | 7.2 % | -65.75 | |
Mar2019 | 21.02 % | - |
WINDLAS BIOTECH Earnings Per Share (EPS)
[BOM: 543329|NSE : WINDLAS]
Y-o-Y | 16.53 % |
5 Yr CAGR | -32.74 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹20 | 16.53 | |
Mar2022 | ₹17 | -29.23 | |
Mar2021 | ₹25 | -2.33 | |
Mar2020 | ₹25 | -74.60 | |
Mar2019 | ₹100 | - |
WINDLAS BIOTECH Return on Capital Employed (ROCE)
[BOM: 543329|NSE : WINDLAS]
Y-o-Y | -3.29 % |
5 Yr CAGR | -22.79 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 14.39% | -3.29 | |
Mar2022 | 14.88% | 49.85 | |
Mar2021 | 9.93% | -34.02 | |
Mar2020 | 15.05% | -62.83 | |
Mar2019 | 40.49% | - |
WINDLAS BIOTECH Share Price vs Sensex
Current Share Price | : | ₹546.2 |
Current MarketCap | : | ₹ 1,136.1 Cr |
Updated EOD on | : | Apr 26,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | -3.9% |
2.9% |
118.3% |
SENSEX | 0.9% |
1.5% |
23.6% |
WINDLAS BIOTECH related INDICES
You may also like the below Video Courses
FAQ about WINDLAS BIOTECH Financials
How the annual revenues of WINDLAS BIOTECH have changed ?
The Revenues of WINDLAS BIOTECH have increased by 8.96% YoY .
How the Earnings per Share (EPS) of WINDLAS BIOTECH have changed?
The Earnings Per Share (EPS) of WINDLAS BIOTECH has increased by 16.53 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs